Home
>
US Stocks
>
Sol-Gel Technologies Ltd
Sol-Gel Technologies Ltd
SLGL

Sol-Gel Technologies Ltd (SLGL)

$8.985.77%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$8.98
Today Low/High
$8.98 / $8.98
52 Week Low/High
$7 / $16.69
Market Cap
$211.86M

Company Details

Sol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Sol-Gel leverages its proprietary microencapsulation technology platform for the development of Twyneo, under investigation for the treatment of acne vulgaris, and Epsolay, under investigation for the treatment of inflammatory lesions of rosacea. The Company's pipeline also includes SGT-210 (erlotinib gel), under investigation for the treatment of palmoplantar keratoderma, and three pre-clinical assets - erlotinib, tapinarof and roflumilast - currently being tested for various pharmaceutical indications.
Organisation
Sol-Gel Technologies Ltd
Headquaters
7 Golda Meir, Ness Ziona, Israel
Employees
65
Industry
Health Technology
CEO
Alon Seri-Levy

Discover more

Frequently Asked Questions

What is Sol-Gel Technologies Ltd (SLGL) share price today?

Can Indians buy Sol-Gel Technologies Ltd (SLGL) shares?

How can I buy Sol-Gel Technologies Ltd (SLGL) shares from India?

Can Fractional shares of Sol-Gel Technologies Ltd (SLGL) be purchased?

What are the documents required to start investing in Sol-Gel Technologies Ltd (SLGL) stocks?

We are a SEBI registered investement advisor